OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 23
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 23
Showing 23 citing articles:
Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy
Ting Zheng, Taotao Jiang, Hongxiang Ma, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7930-7949
Closed Access | Times Cited: 15
Ting Zheng, Taotao Jiang, Hongxiang Ma, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7930-7949
Closed Access | Times Cited: 15
Role of metabolic dysfunction and inflammation along the liver–brain axis in animal models with obesity-induced neurodegeneration
Evridiki Asimakidou, Eka Norfaishanty Saipuljumri, Chih Hung Lo, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 4, pp. 1069-1076
Open Access | Times Cited: 10
Evridiki Asimakidou, Eka Norfaishanty Saipuljumri, Chih Hung Lo, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 4, pp. 1069-1076
Open Access | Times Cited: 10
The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
Bedri Ranxhi, Zoya R. Bangash, Zachary M. Chbihi, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 18
Open Access | Times Cited: 1
Bedri Ranxhi, Zoya R. Bangash, Zachary M. Chbihi, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 18
Open Access | Times Cited: 1
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system
Zoë Donders, Iga Joanna Skorupska, Emily Willems, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117009-117009
Open Access | Times Cited: 7
Zoë Donders, Iga Joanna Skorupska, Emily Willems, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117009-117009
Open Access | Times Cited: 7
Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling
Jinfang Hao, Xiaoyan Zhang, Ruixian Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Jinfang Hao, Xiaoyan Zhang, Ruixian Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases
Dominika Kołodziej, Łukasz Sobczak, Krzysztof Z. Łączkowski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7033-7033
Open Access | Times Cited: 5
Dominika Kołodziej, Łukasz Sobczak, Krzysztof Z. Łączkowski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7033-7033
Open Access | Times Cited: 5
2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione protects against MPP+-induced neurotoxicity by ameliorating oxidative stress, apoptosis and autophagy in SH-SY5Y cells
Kechen Du, Ying Su, Qiong Song, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Kechen Du, Ying Su, Qiong Song, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Investigating the Interplay Between the Nrf2/Keap1/HO-1/SIRT-1 Pathway and the p75NTR/PI3K/Akt/MAPK Cascade in Neurological Disorders: Mechanistic Insights and Therapeutic Innovations
R Mukherjee, R.S. Rana, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
R Mukherjee, R.S. Rana, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Artemether exerts neuroprotective effect in Parkinson’s disease through the PI3K/Akt/GSK-3β signaling pathway
Shengli Quan, Jinhua Li, Shuxian Ding, et al.
European Journal of Pharmacology (2025), pp. 177566-177566
Closed Access
Shengli Quan, Jinhua Li, Shuxian Ding, et al.
European Journal of Pharmacology (2025), pp. 177566-177566
Closed Access
Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
Kenneth Maiese
Cells (2023) Vol. 12, Iss. 22, pp. 2595-2595
Open Access | Times Cited: 11
Kenneth Maiese
Cells (2023) Vol. 12, Iss. 22, pp. 2595-2595
Open Access | Times Cited: 11
Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways
Hend A. Hamouda, Rabab H. Sayed, Nihad I. Eid, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 1017-1033
Open Access | Times Cited: 4
Hend A. Hamouda, Rabab H. Sayed, Nihad I. Eid, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 1017-1033
Open Access | Times Cited: 4
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Neuroprotective effects of punicalagin and/or micronized zeolite clinoptilolite on manganese‐induced Parkinson's disease in a rat model: Involvement of multiple pathways
Karema Abu‐Elfotuh, Ashwaq N. Abbas, Mazin A. A. Najm, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 3
Karema Abu‐Elfotuh, Ashwaq N. Abbas, Mazin A. A. Najm, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 3
Intranasal delivery of liposome encapsulated flavonoids ameliorates L-DOPA induced dyskinesia in hemiparkinsonian mice
Mohamed Rafiuddin Ahmed, Mohammed Inayathullah, Mithya Morton, et al.
Biomaterials (2024) Vol. 311, pp. 122680-122680
Closed Access | Times Cited: 2
Mohamed Rafiuddin Ahmed, Mohammed Inayathullah, Mithya Morton, et al.
Biomaterials (2024) Vol. 311, pp. 122680-122680
Closed Access | Times Cited: 2
Artificial Intelligence and Disease Signature Pathways: Driving Innovation to Elucidate Underlying Pathogenic Mechanisms
Kenneth Maiese
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 229-233
Closed Access | Times Cited: 1
Kenneth Maiese
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 229-233
Closed Access | Times Cited: 1
Costunolide ameliorates rotenone-induced Parkinson's disease in rat model via activation of SIRT-1/p-AMPK cascade and suppression of IL-6/STAT3 axis
Alaa Sirwi, Nesrine S. El Sayed, Dina A. I. Albadawi, et al.
Scientific African (2024) Vol. 26, pp. e02470-e02470
Open Access | Times Cited: 1
Alaa Sirwi, Nesrine S. El Sayed, Dina A. I. Albadawi, et al.
Scientific African (2024) Vol. 26, pp. e02470-e02470
Open Access | Times Cited: 1
Chemical composition and studying the possible neuroprotective effect of iridoids-rich fraction from Pentas lanceolata leaves using rotenone model of Parkinson’s disease in mice
Ahmed M. Afifi, Heba-tollah M. Sweelam, Marwa El-Sayed El-Shamarka, et al.
Research Square (Research Square) (2024)
Open Access
Ahmed M. Afifi, Heba-tollah M. Sweelam, Marwa El-Sayed El-Shamarka, et al.
Research Square (Research Square) (2024)
Open Access
Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson’s disease model
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Prajwal P. Kunte, et al.
Journal of drug targeting (2024) Vol. 33, Iss. 1, pp. 127-142
Closed Access
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Prajwal P. Kunte, et al.
Journal of drug targeting (2024) Vol. 33, Iss. 1, pp. 127-142
Closed Access
Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study
Yan Wang, Peng-Peng Gao, Zicong Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119095-119095
Closed Access
Yan Wang, Peng-Peng Gao, Zicong Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119095-119095
Closed Access
Chemical composition and studying the possible neuroprotective effect of iridoids-rich fraction from Pentas lanceolata leaves using rotenone model of Parkinson’s disease in mice
Ahmed H. Afifi, Heba-tollah M. Sweelam, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3953-3971
Open Access
Ahmed H. Afifi, Heba-tollah M. Sweelam, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3953-3971
Open Access
Phosphodiesterase 4 (PDE4) and neurological disorders: A promising frontier in neuropharmacology
Sumaiya Nahid, Saeedeh Saeedi, Corey R. Hopkins
Advances in pharmacology (2024), pp. 159-209
Closed Access
Sumaiya Nahid, Saeedeh Saeedi, Corey R. Hopkins
Advances in pharmacology (2024), pp. 159-209
Closed Access
Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways
Kenneth Maiese
World Journal of Cardiology (2024) Vol. 16, Iss. 11, pp. 632-643
Open Access
Kenneth Maiese
World Journal of Cardiology (2024) Vol. 16, Iss. 11, pp. 632-643
Open Access
